Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes

被引:27
作者
Perez, M
Jorand-Lebrun, C
Pauwels, PJ
Pallard, I
Halazy, S
机构
[1] Ctr Rech Pierre Fabre, Div Med Chem, F-81106 Castres, France
[2] Ctr Rech Pierre Fabre, Dept Cellular & Mol Biol, F-81106 Castres, France
关键词
D O I
10.1016/S0960-894X(98)00222-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New dimers of known 5HT(1) ligands (5HT, 1-NP or 8-OH-DPAT) have, been prepared and evaluated at human cloned 5HT(1B), 5HT(1D) and 5HT(1A) receptors. Binding experiments show that all these dimers have better affinities at 5HT(1B/1D) receptors than their corresponding monomeric ligands. Studies of inhibition of the forskolin-stimulated c-AMP formation mediated by the human 5HT(1B) receptor show that hetero-bivalent ligands [combining an agonist (5HT) with an antagonist (I-NP)] behave as partial agonists while the intrinsic activity of bivalent antagonists (combining two I-NP residues) was found to be spacer dependent. Surprisingly enough, the dimer of 8-OH-DPAT 6 binds to 5HT(1A), 5HT(1B) and 5HT(1D) receptors with similar high affinity, (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1407 / 1412
页数:6
相关论文
共 20 条
[1]  
Branchek T, 1997, ANNU REP MED CHEM, V32, P1, DOI 10.1016/S0065-7743(08)61459-1
[2]  
FINK K, 1995, N-S ARCH PHARMACOL, V352, P451
[3]   5-HT1D SEROTONIN RECEPTORS - RESULTS OF A STRUCTURE-AFFINITY INVESTIGATION [J].
GLENNON, RA ;
ISMAIEL, AM ;
CHAURASIA, C ;
TITELER, M .
DRUG DEVELOPMENT RESEARCH, 1991, 22 (01) :25-36
[4]  
GLENNON RA, 1997, SEROTONIN, V2, P351
[5]   Serotonin dimers: Application of the bivalent ligand approach to the design of new potent and selective 5-HT1B/1D agonists [J].
Halazy, S ;
Perez, M ;
Fourrier, C ;
Pallard, I ;
Pauwels, PJ ;
Palmier, C ;
John, GW ;
Valentin, JP ;
Bonnafous, R ;
Martinez, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4920-4927
[6]   5-HT1B/1D antagonists and depression [J].
Halazy, S ;
Lamothe, M ;
JorandLebrun, C .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (04) :339-352
[7]  
HAMEL E, 1996, SEROTONIN ID RES ALE, V1, P19
[8]   Alignment of receptor nomenclature with the human genome: Classification of 5-HT1B and 5-HT1D receptor subtypes [J].
Hartig, PR ;
Hoyer, D ;
Humphrey, PPA ;
Martin, GR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (03) :103-105
[9]   5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine [J].
JorandLebrun, C ;
Pauwels, PJ ;
Palmier, C ;
Moret, C ;
Chopin, P ;
Perez, M ;
Marien, M ;
Halazy, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (24) :3974-3978
[10]  
MORET C, 1995, N-S ARCH PHARMACOL, V351, P377